Is a complete AVBP research report available?

No complete published report is available for ArriVent BioPharma, Inc. (AVBP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ArriVent BioPharma, Inc. (AVBP)

NASDAQ: AVBP · USD

$15.8

+0.37 (+2.4%)· Recorded snapshot

Market cap	777.6M
Net income (ttm)	-164.2M
EPS (ttm)	-$3.70
Shares out	49.3M
Volume	800,609
Beta	1.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -164.2M
EPS (ttm): -$3.70
Market cap: 777.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Metric	Value
Amount currency	USD
CIK code	0001868279
Company name	ArriVent BioPharma, Inc.
Country	United States
Country code	US
CUSIP number	04272N102
Earnings date	2026-11-09
Earnings time	bmo
Employees	77
Employees change	25
Employees growth	48.08%
Enterprise value	$404.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2021
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2024-01-26
Is primary listing	Yes
Is SPAC	No
ISIN number	US04272N1028
Last 10-K release date	2026-03-05
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$777.6M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$15.77
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	AVBP
U.S. state	Pennsylvania
Website	https://arrivent.com

Metric

Value

Amount currency

USD

CIK code

0001868279

Company name

ArriVent BioPharma, Inc.

Country

United States

Country code

CUSIP number

04272N102

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

Employees growth

48.08%

Enterprise value

$404.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2021

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2024-01-26

Is primary listing

Yes

Is SPAC

ISIN number

US04272N1028

Last 10-K release date

2026-03-05

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$777.6M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$15.77

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

AVBP

U.S. state

Pennsylvania

Website

https://arrivent.com

Metric	Value
Earnings yield	-23.45%
FCF / EV yield	-37.6%
FCF yield	-19.31%
Forward EV/Sales	51.58x
Forward P/S	100.44x
P/B ratio	2.03x
Price / tangible book value	2.09x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-23.45%

FCF / EV yield

-37.6%

FCF yield

-19.31%

Forward EV/Sales

51.58x

Forward P/S

100.44x

P/B ratio

2.03x

Price / tangible book value

2.09x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-2.1M
ROA	-33.11%
ROCE	-47.96%
ROE	-53.25%
ROIC	-35.64%

Metric

Value

Profit per employee

$-2.1M

ROA

-33.11%

ROCE

-47.96%

ROE

-53.25%

ROIC

-35.64%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
EBIT	$-175.9M
EPS	$-3.70
FCF per share	$-3.00
Financing cash flow	$262.2M
Free cash flow	$-147.9M
Free cash flow minus SBC	$-167M
Investing cash flow	$-72.3M
Net cash flow	$41.9M
Net income	$-164.2M
Operating cash flow minus SBC	$-167M
Operating income	$-175.9M
Stock-based compensation	$19.1M

Metric

Value

EBIT

$-175.9M

EPS

$-3.70

FCF per share

$-3.00

Financing cash flow

$262.2M

Free cash flow

$-147.9M

Free cash flow minus SBC

$-167M

Investing cash flow

$-72.3M

Net cash flow

$41.9M

Net income

$-164.2M

Operating cash flow minus SBC

$-167M

Operating income

$-175.9M

Stock-based compensation

$19.1M

Metric	Value
Book value per share	$7.59
Debt / equity	0
Long-term assets	$545,000
Long-term liabilities	$33,000
Net cash (debt)	$372.8M
Net cash / market cap	48.65%
Net cash growth	58.23%
Net debt / equity	-1.02
Piotroski F-Score	2
Property, plant and equipment	$370,000
Shareholders' equity	$366.8M
Tangible book value	$366.8M
Tangible book value per share	$7.59
Total assets	$394.7M
Total cash	$373.1M
Total debt	$351,000
Total liabilities	$27.9M
WACC	11.67%

Metric

Value

Book value per share

$7.59

Debt / equity

Long-term assets

$545,000

Long-term liabilities

$33,000

Net cash (debt)

$372.8M

Net cash / market cap

48.65%

Net cash growth

58.23%

Net debt / equity

-1.02

Piotroski F-Score

Property, plant and equipment

$370,000

Shareholders' equity

$366.8M

Tangible book value

$366.8M

Tangible book value per share

$7.59

Total assets

$394.7M

Total cash

$373.1M

Total debt

$351,000

Total liabilities

$27.9M

WACC

11.67%

Metric	Value
Current assets	$394.2M
Current liabilities	$27.8M
Current ratio	14.16
Net working capital	$-6.5M
Quick ratio	13.4
Working capital	$366.3M

Metric

Value

Current assets

$394.2M

Current liabilities

$27.8M

Current ratio

14.16

Net working capital

$-6.5M

Quick ratio

13.4

Working capital

$366.3M

Metric	Value
Buyback yield / dilution	-30.39%
Dividend yield	0%
Shareholder yield	-30.39%

Metric

Value

Buyback yield / dilution

-30.39%

Dividend yield

Shareholder yield

-30.39%

Metric	Value
150-day SMA	$28.36
1D price change	2.4%
1M price change	-45.59%
1M total return	-45.59%
1W price change	-17.88%
1W total return	-17.88%
1Y price change	-20.57%
1Y return CAGR	-20.59%
1Y total return	-20.57%
20-day SMA	$18.78
200-day SMA	$27.02
3M price change	-48.67%
3M total return	-48.67%
50-day SMA	$25.32
50-day SMA vs 200-day SMA	50under200
52-week high	$35.83
52-week high date	2026-06-26
52-week low	$11.36
52-week low date	2026-10-06
6M price change	-48.96%
6M total return	-48.96%
All-time high	$36.37
All-time high date	2024-11-08
All-time low	$11.36
All-time low date	2026-10-06
Average true range (ATR)	$1.93
Average volume	2.6M
Beta (1Y)	1.18
Beta (2Y)	1.24
Beta (5Y)	1.35
Change from 52-week high	-55.99%
Change from 52-week low	38.82%
Change from all-time high	-57.44%
Change from all-time low	36.27%
Change from open	2.74%
Day's gap	-0.32%
Dollar volume	$12.6M
High price	$15.87
Low price	$15.35
Monthly RSI	38.6
Open price	$15.35
Position in 52-week range	80.77%
Premarket change	3.9%
Premarket close	$15.40
Premarket price	$16.00
Premarket volume	1.6K
Previous close	$15.40
Price vs 150-day SMA	-45.41%
Price vs 20-day SMA	-17.58%
Price vs 200-day SMA	-42.71%
Price vs 50-day SMA	-38.85%
Relative volume	0.31
Return from IPO open	-35.25%
Return from IPO price	-13.67%
RSI	32.58
Sharpe ratio	0.13
Sortino ratio	0.23
Volume	800.6K
Weekly RSI	31.48
YTD price change	-23.06%
YTD total return	-23.06%

Metric

Value

150-day SMA

$28.36

1D price change

2.4%

1M price change

-45.59%

1M total return

-45.59%

1W price change

-17.88%

1W total return

-17.88%

1Y price change

-20.57%

1Y return CAGR

-20.59%

1Y total return

-20.57%

20-day SMA

$18.78

200-day SMA

$27.02

3M price change

-48.67%

3M total return

-48.67%

50-day SMA

$25.32

50-day SMA vs 200-day SMA

50under200

52-week high

$35.83

52-week high date

2026-06-26

52-week low

$11.36

52-week low date

2026-10-06

6M price change

-48.96%

6M total return

-48.96%

All-time high

$36.37

All-time high date

2024-11-08

All-time low

$11.36

All-time low date

2026-10-06

Average true range (ATR)

$1.93

Average volume

2.6M

Beta (1Y)

1.18

Beta (2Y)

1.24

Beta (5Y)

1.35

Change from 52-week high

-55.99%

Change from 52-week low

38.82%

Change from all-time high

-57.44%

Change from all-time low

36.27%

Change from open

2.74%

Day's gap

-0.32%

Dollar volume

$12.6M

High price

$15.87

Low price

$15.35

Monthly RSI

38.6

Open price

$15.35

Position in 52-week range

80.77%

Premarket change

3.9%

Premarket close

$15.40

Premarket price

$16.00

Premarket volume

1.6K

Previous close

$15.40

Price vs 150-day SMA

-45.41%

Price vs 20-day SMA

-17.58%

Price vs 200-day SMA

-42.71%

Price vs 50-day SMA

-38.85%

Relative volume

0.31

Return from IPO open

-35.25%

Return from IPO price

-13.67%

RSI

32.58

Sharpe ratio

0.13

Sortino ratio

0.23

Volume

800.6K

Weekly RSI

31.48

YTD price change

-23.06%

YTD total return

-23.06%

Metric	Value
Float	29.6M
Float percentage	60.1%
Shares change (QoQ)	5.63%
Shares change (YoY)	30.39%
Shares held by insiders	1.82%
Shares held by institutions	66.81%
Shares outstanding	49.3M
Short % of float	28.52%
Short % of shares	17.14%
Short ratio	13.5 days

Metric

Value

Float

29.6M

Float percentage

60.1%

Shares change (QoQ)

5.63%

Shares change (YoY)

30.39%

Shares held by insiders

1.82%

Shares held by institutions

66.81%

Shares outstanding

49.3M

Short % of float

28.52%

Short % of shares

17.14%

Short ratio

13.5 days

ArriVent BioPharma, Inc. (AVBP)

Price

Financial snapshot

Fair-value bridge

Latest news · AVBP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AVBP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AVBP

Frequently asked questions